COVID-19 Impact on Genomic Biomarkers Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Genomic Biomarkers Industry
1.7 COVID-19 Impact: Genomic Biomarkers Market Trends
2 Global Genomic Biomarkers Quarterly Market Size Analysis
2.1 Genomic Biomarkers Business Impact Assessment - COVID-19
2.1.1 Global Genomic Biomarkers Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Genomic Biomarkers Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Genomic Biomarkers Quarterly Market Size, 2019 VS 2020
3.2 By Players, Genomic Biomarkers Headquarters and Area Served
3.3 Date of Key Players Enter into Genomic Biomarkers Market
3.4 Key Players Genomic Biomarkers Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Genomic Biomarkers Segments, By Type
4.1 Introduction
1.4.1 Oncology
1.4.2 Cardiovascular diseases
1.4.3 Neurological diseases
1.4.4 Others
4.2 By Type, Global Genomic Biomarkers Market Size, 2019-2021
5 Impact of Covid-19 on Genomic Biomarkers Segments, By Application
5.1 Overview
5.5.1 Diagnostic and research laboratories
5.5.2 Hospitals
5.5.3 Others
5.2 By Application, Global Genomic Biomarkers Market Size, 2019-2021
5.2.1 By Application, Global Genomic Biomarkers Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Business Overview
7.1.2 Thermo Fisher Scientific Genomic Biomarkers Quarterly Revenue, 2020
7.1.3 Thermo Fisher Scientific Genomic Biomarkers Product Introduction
7.1.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
7.2 Roche
7.2.1 Roche Business Overview
7.2.2 Roche Genomic Biomarkers Quarterly Revenue, 2020
7.2.3 Roche Genomic Biomarkers Product Introduction
7.2.4 Roche Response to COVID-19 and Related Developments
7.3 Aepodia
7.3.1 Aepodia Business Overview
7.3.2 Aepodia Genomic Biomarkers Quarterly Revenue, 2020
7.3.3 Aepodia Genomic Biomarkers Product Introduction
7.3.4 Aepodia Response to COVID-19 and Related Developments
7.4 Myriad Genetics
7.4.1 Myriad Genetics Business Overview
7.4.2 Myriad Genetics Genomic Biomarkers Quarterly Revenue, 2020
7.4.3 Myriad Genetics Genomic Biomarkers Product Introduction
7.4.4 Myriad Genetics Response to COVID-19 and Related Developments
7.5 Eurofins Scientific
7.5.1 Eurofins Scientific Business Overview
7.5.2 Eurofins Scientific Genomic Biomarkers Quarterly Revenue, 2020
7.5.3 Eurofins Scientific Genomic Biomarkers Product Introduction
7.5.4 Eurofins Scientific Response to COVID-19 and Related Developments
7.6 QIAGEN
7.6.1 QIAGEN Business Overview
7.6.2 QIAGEN Genomic Biomarkers Quarterly Revenue, 2020
7.6.3 QIAGEN Genomic Biomarkers Product Introduction
7.6.4 QIAGEN Response to COVID-19 and Related Developments
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Business Overview
7.7.2 Bio-Rad Laboratories Genomic Biomarkers Quarterly Revenue, 2020
7.7.3 Bio-Rad Laboratories Genomic Biomarkers Product Introduction
7.7.4 Bio-Rad Laboratories Response to COVID-19 and Related Developments
7.8 Genomic Health
7.8.1 Genomic Health Business Overview
7.8.2 Genomic Health Genomic Biomarkers Quarterly Revenue, 2020
7.8.3 Genomic Health Genomic Biomarkers Product Introduction
7.8.4 Genomic Health Response to COVID-19 and Related Developments
7.9 Liquid Genomics
7.9.1 Liquid Genomics Business Overview
7.9.2 Liquid Genomics Genomic Biomarkers Quarterly Revenue, 2020
7.9.3 Liquid Genomics Genomic Biomarkers Product Introduction
7.9.4 Liquid Genomics Response to COVID-19 and Related Developments
7.10 Epigenomics
7.10.1 Epigenomics Business Overview
7.10.2 Epigenomics Genomic Biomarkers Quarterly Revenue, 2020
7.10.3 Epigenomics Genomic Biomarkers Product Introduction
7.10.4 Epigenomics Response to COVID-19 and Related Developments
7.11 AROS Applied Biotechnology
7.11.1 AROS Applied Biotechnology Business Overview
7.11.2 AROS Applied Biotechnology Genomic Biomarkers Quarterly Revenue, 2020
7.11.3 AROS Applied Biotechnology Genomic Biomarkers Product Introduction
7.11.4 AROS Applied Biotechnology Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Genomic Biomarkers Assessment
Table 9. COVID-19 Impact: Genomic Biomarkers Market Trends
Table 10. COVID-19 Impact Global Genomic Biomarkers Market Size
Table 11. Global Genomic Biomarkers Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Genomic Biomarkers Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Genomic Biomarkers Market Growth Drivers
Table 14. Global Genomic Biomarkers Market Restraints
Table 15. Global Genomic Biomarkers Market Opportunities
Table 16. Global Genomic Biomarkers Market Challenges
Table 17. By Players, Genomic Biomarkers Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Genomic Biomarkers Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Genomic Biomarkers Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Genomic Biomarkers Market
Table 21. Key Players Genomic Biomarkers Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Genomic Biomarkers Market Size 2019-2021, (US$ Million)
Table 24. Global Genomic Biomarkers Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Genomic Biomarkers Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Genomic Biomarkers Market Size, 2019-2021 (US$ Million)
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific Genomic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Thermo Fisher Scientific Genomic Biomarkers Product
Table 60. Thermo Fisher Scientific Response to COVID-19 and Related Developments
Table 61. Roche Business Overview
Table 62. Roche Genomic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Roche Genomic Biomarkers Product
Table 64. Roche Response to COVID-19 and Related Developments
Table 65. Aepodia Business Overview
Table 66. Aepodia Genomic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Aepodia Genomic Biomarkers Product
Table 68. Aepodia Response to COVID-19 and Related Developments
Table 69. Myriad Genetics Business Overview
Table 70. Myriad Genetics Genomic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Myriad Genetics Genomic Biomarkers Product
Table 72. Myriad Genetics Response to COVID-19 and Related Developments
Table 73. Eurofins Scientific Business Overview
Table 74. Eurofins Scientific Genomic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Eurofins Scientific Genomic Biomarkers Product
Table 76. Eurofins Scientific Response to COVID-19 and Related Developments
Table 77. QIAGEN Business Overview
Table 78. QIAGEN Genomic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. QIAGEN Genomic Biomarkers Product
Table 80. QIAGEN Response to COVID-19 and Related Developments
Table 81. Bio-Rad Laboratories Business Overview
Table 82. Bio-Rad Laboratories Genomic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Bio-Rad Laboratories Genomic Biomarkers Product
Table 84. Bio-Rad Laboratories Response to COVID-19 and Related Developments
Table 85. Genomic Health Business Overview
Table 86. Genomic Health Genomic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Genomic Health Genomic Biomarkers Product
Table 88. Genomic Health Response to COVID-19 and Related Developments
Table 89. Liquid Genomics Business Overview
Table 90. Liquid Genomics Genomic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Liquid Genomics Genomic Biomarkers Product
Table 92. Liquid Genomics Response to COVID-19 and Related Developments
Table 93. Epigenomics Business Overview
Table 94. Epigenomics Genomic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Epigenomics Genomic Biomarkers Product
Table 96. Epigenomics Response to COVID-19 and Related Developments
Table 97. AROS Applied Biotechnology Business Overview
Table 98. AROS Applied Biotechnology Genomic Biomarkers Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. AROS Applied Biotechnology Genomic Biomarkers Product
Table 100. AROS Applied Biotechnology Response to COVID-19 and Related Developments
List of FiguresFigure 1. Genomic Biomarkers Product Picture
Figure 2. Genomic Biomarkers Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Genomic Biomarkers Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Genomic Biomarkers Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Genomic Biomarkers Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Genomic Biomarkers Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Genomic Biomarkers Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Genomic Biomarkers Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Genomic Biomarkers Market Size Market Share, 2019-2021